Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
LOI, Sherene, SIRTAINE, Nicolas, DE AZAMBUJA, Evandro, QUINAUX, Emmanuel, DI LEO, Angelo, MICHIELS, Stefan, PICCART, Martine J, SOTIRIOU, Christos, PIETTE, Fanny, SALGADO, Roberto, VIALE, Giuseppe, VAN EENOO, Françoise, ROUAS, Ghizlane, FRANCIS, Prudence, CROWN, John P. A, HITRE, Erika
Published in Journal of clinical oncology (01.03.2013)
Published in Journal of clinical oncology (01.03.2013)
Get full text
Journal Article
HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data
Leo, Angelo Di, Dr, Desmedt, Christine, PhD, Bartlett, John M S, Prof, Piette, Fanny, PhD, Ejlertsen, Bent, MD, Pritchard, Kathleen I, Prof, Larsimont, Denis, MD, Poole, Christopher, Prof, Isola, Jorma, Prof, Earl, Helena, Prof, Mouridsen, Henning, MD, O'Malley, Frances P, MD, Cardoso, Fatima, MD, Tanner, Minna, MD, Munro, Alison, PhD, Twelves, Chris J, Prof, Sotiriou, Christos, MD, Shepherd, Lois, MD, Cameron, David, Prof, Piccart, Martine J, Prof, Buyse, Marc, PhD
Published in The lancet oncology (01.11.2011)
Published in The lancet oncology (01.11.2011)
Get full text
Journal Article
Comparison of prognostic gene expression signatures for breast cancer
Haibe-Kains, Benjamin, Desmedt, Christine, Piette, Fanny, Buyse, Marc, Cardoso, Fatima, Van't Veer, Laura, Piccart, Martine, Bontempi, Gianluca, Sotiriou, Christos
Published in BMC genomics (21.08.2008)
Published in BMC genomics (21.08.2008)
Get full text
Journal Article
Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series
DESMEDT, Christine, PIETTE, Fanny, BERGH, Jonas, LIDEREAU, Rosette, ELLIS, Paul, HARRIS, Adrian L, KLIJN, Jan G. M, FOEKENS, John A, CARDOSO, Fatima, PICCART, Martine J, BUYSE, Marc, SOTIRIOU, Christos, LOI, Sherene, YIXIN WANG, LALLEMAND, Frangoise, HAIBE-KAINS, Benjamin, VIALE, Giuseppe, DELORENZI, Mauro, YI ZHANG, SAGHATCHIAN D'ASSIGNIES, Mahasti
Published in Clinical cancer research (01.06.2007)
Published in Clinical cancer research (01.06.2007)
Get full text
Journal Article
Conference Proceeding
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2 + breast cancer
Jacobs, Samuel A, Robidoux, André, Abraham, Jame, Pérez-Garcia, José Manuel, La Verde, Nicla, Orcutt, James M, Cazzaniga, Marina E, Piette, Fanny, Antolín, Silvia, Aguirre, Elena, Cortes, Javier, Llombart-Cussac, Antonio, Di Cosimo, Serena, Kim, Rim S, Feng, Huichen, Lipchik, Corey, Lucas, Peter C, Srinivasan, Ashok, Wang, Ying, Song, Nan, Gavin, Patrick G, Balousek, April D, Paik, Soonmyung, Allegra, Carmen J, Wolmark, Norman, Pogue-Geile, Katherine L
Published in Breast cancer research : BCR (03.12.2019)
Published in Breast cancer research : BCR (03.12.2019)
Get full text
Journal Article
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer
Jacobs, Samuel A, Wang, Ying, Abraham, Jame, Feng, Huichen, Montero, Alberto J, Lipchik, Corey, Finnigan, Melanie, Jankowitz, Rachel C, Salkeni, Mohamad A, Maley, Sai K, Puhalla, Shannon L, Piette, Fanny, Quinn, Katie, Chang, Kyle, Nagy, Rebecca J, Allegra, Carmen J, Vehec, Kelly, Wolmark, Norman, Lucas, Peter C, Srinivasan, Ashok, Pogue-Geile, Katherine L
Published in Breast cancer research : BCR (22.04.2024)
Published in Breast cancer research : BCR (22.04.2024)
Get full text
Journal Article
Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer
Jacobs, Samuel A, Wang, Ying, Abraham, Jame, Feng, Huichen, Montero, Alberto J, Lipchik, Corey, Finnigan, Melanie, Jankowitz, Rachel C, Salkeni, Mohamad A, Maley, Sai K, Puhalla, Shannon L, Piette, Fanny, Quinn, Katie, Chang, Kyle, Nagy, Rebecca J, Allegra, Carmen J, Vehec, Kelly, Wolmark, Norman, Lucas, Peter C, Srinivasan, Ashok, Pogue-Geile, Katherine L
Published in Breast cancer research : BCR (24.05.2024)
Published in Breast cancer research : BCR (24.05.2024)
Get full text
Journal Article
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
Jacobs, Samuel A, Robidoux, André, Abraham, Jame, Pérez-Garcia, José Manuel, La Verde, Nicla, Orcutt, James M, Cazzaniga, Marina E, Piette, Fanny, Antolín, Silvia, Aguirre, Elena, Cortes, Javier, Llombart-Cussac, Antonio, Di Cosimo, Serena, Kim, Rim S, Feng, Huichen, Lipchik, Corey, Lucas, Peter C, Srinivasan, Ashok, Wang, Ying, Song, Nan, Gavin, Patrick G, Balousek, April D, Paik, Soonmyung, Allegra, Carmen J, Wolmark, Norman, Pogue-Geile, Katherine L
Published in Breast cancer research : BCR (22.01.2020)
Published in Breast cancer research : BCR (22.01.2020)
Get full text
Journal Article
Correlation Between Quantitative HER‐2 Protein Expression and Risk for Brain Metastases in HER‐2+ Advanced Breast Cancer Patients Receiving Trastuzumab‐Containing Therapy
Duchnowska, Renata, Biernat, Wojciech, Szostakiewicz, Barbara, Sperinde, Jeff, Piette, Fanny, Haddad, Mojgan, Paquet, Agnes, Lie, Yolanda, Czartoryska‐Arłukowicz, Bogumiła, Wysocki, Piotr, Jankowski, Tomasz, Radecka, Barbara, Foszczyńska‐Kłoda, Małgorzata, Litwiniuk, Maria, Dȩbska, Sylwia, Weidler, Jodi, Huang, Weidong, Buyse, Marc, Bates, Michael, Jassem, Jacek
Published in The oncologist (Dayton, Ohio) (01.01.2012)
Published in The oncologist (Dayton, Ohio) (01.01.2012)
Get full text
Journal Article
Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10
Abraham, Jame, Montero, Albert J, Jankowitz, Rachel C, Salkeni, Mohamad Adham, Beumer, Jan H, Kiesel, Brian F, Piette, Fanny, Adamson, Laura M, Nagy, Rebecca J, Lanman, Richard B, Sperinde, Jeff, Huang, Weidong, Allegra, Carmen J, Srinivasan, Ashok, Wang, Ying, Pogue-Geile, Katherine L, Lucas, Peter C, Jacobs, Samuel A
Published in Journal of clinical oncology (10.10.2019)
Published in Journal of clinical oncology (10.10.2019)
Get full text
Journal Article
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer
Buyse, Marc, Loi, Sherene, van't Veer, Laura, Viale, Giuseppe, Delorenzi, Mauro, Glas, Annuska M., Saghatchian d'Assignies, Mahasti, Bergh, Jonas, Lidereau, Rosette, Ellis, Paul, Harris, Adrian, Bogaerts, Jan, Therasse, Patrick, Floore, Arno, Amakrane, Mohamed, Piette, Fanny, Rutgers, Emiel, Sotiriou, Christos, Cardoso, Fatima, Piccart, Martine J.
Published in JNCI : Journal of the National Cancer Institute (06.09.2006)
Published in JNCI : Journal of the National Cancer Institute (06.09.2006)
Get full text
Journal Article
Neratinib-Plus-Cetuximab in Quadruple-WT ( KRAS, NRAS, BRAF, PIK3CA ) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study
Jacobs, Samuel A, Lee, James J, George, Thomas J, Wade, 3rd, James L, Stella, Philip J, Wang, Ding, Sama, Ashwin R, Piette, Fanny, Pogue-Geile, Katherine L, Kim, Rim S, Gavin, Patrick G, Lipchik, Corey, Feng, Huichen, Wang, Ying, Finnigan, Melanie, Kiesel, Brian F, Beumer, Jan H, Wolmark, Norman, Lucas, Peter C, Allegra, Carmen J, Srinivasan, Ashok
Published in Clinical cancer research (15.03.2021)
Published in Clinical cancer research (15.03.2021)
Get full text
Journal Article
Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types
Lonez, Caroline, Verma, Bikash, Hendlisz, Alain, Aftimos, Philippe, Awada, Ahmad, Van Den Neste, Eric, Catala, Gaetan, Machiels, Jean-Pascal H, Piette, Fanny, Brayer, Jason B, Sallman, David A, Kerre, Tessa, Odunsi, Kunle, Davila, Marco L, Gilham, David E, Lehmann, Frédéric F
Published in BMJ open (01.11.2017)
Published in BMJ open (01.11.2017)
Get full text
Journal Article
Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation
Chapiro, Jacques, Claverol, Stephane, Piette, Fanny, Ma, Wenbin, Stroobant, Vincent, Guillaume, Benoit, Gairin, Jean-Edouard, Morel, Sandra, Burlet-Schiltz, Odile, Monsarrat, Bernard, Boon, Thierry, Van den Eynde, Benoit J
Published in Journal of Immunology (15.01.2006)
Published in Journal of Immunology (15.01.2006)
Get full text
Journal Article
Correlation Between Quantitative HER‐2 Protein Expression and Risk for Brain Metastases in HER‐2+ Advanced Breast Cancer Patients Receiving Trastuzumab‐Containing Therapy
Duchnowska, Renata, Biernat, Wojciech, Szostakiewicz, Barbara, Sperinde, Jeff, Piette, Fanny, Haddad, Mojgan, Paquet, Agnes, Lie, Yolanda, Czartoryska‐Arłukowicz, Bogumiła, Wysocki, Piotr, Jankowski, Tomasz, Radecka, Barbara, Foszczynska‐Kloda, Malgorzata, Litwiniuk, Maria, Dȩbska, Sylwia, Weidler, Jodi, Huang, Weidong, Buyse, Marc, Bates, Michael, Jassem, Jacek
Published in The oncologist (Dayton, Ohio) (01.06.2013)
Published in The oncologist (Dayton, Ohio) (01.06.2013)
Get full text
Journal Article
Quantitation of HER2 expression or HER2:HER2 dimers and differential survival in a cohort of metastatic breast cancer patients carefully selected for trastuzumab treatment primarily by FISH
Desmedt, Christine, Sperinde, Jeff, Piette, Fanny, Huang, Weidong, Jin, Xueguang, Tan, Yuping, Durbecq, Virginie, Larsimont, Denis, Giuliani, Rosa, Chappey, Colombe, Buyse, Marc, Winslow, John, Piccart, Martine, Sotiriou, Christos, Petropoulos, Christos, Bates, Michael
Published in Diagnostic molecular pathology (01.03.2009)
Published in Diagnostic molecular pathology (01.03.2009)
Get more information
Journal Article
Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group
Rastogi, Priya, Buyse, Marc E, Swain, Sandra M, Jacobs, Samuel A, Robidoux, André, Liepman, Marcia K, Pajon, Eduardo R, Dy, Philip A, Posada, Juan G, Melnik, Marianne K, Piette, Fanny, Geyer, Charles E, Mamounas, Elfetherios P, Wolmark, Norman
Published in Clinical breast cancer (01.08.2011)
Published in Clinical breast cancer (01.08.2011)
Get full text
Journal Article
Unrelated Donor Status and High Donor Age Independently Affect Immunologic Recovery after Nonmyeloablative Conditioning
Baron, Frédéric, Storer, Barry, Maris, Michael B., Storek, Jan, Piette, Fanny, Metcalf, Monja, White, Kristen, Sandmaier, Brenda M., Maloney, David G., Storb, Rainer, Boeckh, Michael
Published in Biology of blood and marrow transplantation (01.11.2006)
Published in Biology of blood and marrow transplantation (01.11.2006)
Get full text
Journal Article
Web Resource
METHODS OF ASSESSING A PROPENSITY OF CLINICAL OUTCOME FOR A FEMALE MAMMAL SUFFERING FROM BREAST CANCER
BIRNBAUM DANIEL, FERT VINCENT, DERACO STEPHANE, DEBONO STEPHANE, PIETTE FANNY, BORIE NATHALIE, BERTUCCI FRANCOIS, HERMITTE FABIENNE, VIENS PATRICE
Year of Publication 16.09.2010
Get full text
Year of Publication 16.09.2010
Patent
METHODS OF ASSESSING A PROPENSITY OF CLINICAL OUTCOME FOR A FEMALE MAMMAL SUFFERING FROM BREAST CANCER
HERMITTE, FABIENNE, FERT, VINCENT, PIETTE, FANNY, BERTUCCI, FRANCOIS, BIRNBAUM, DANIEL, DEBONO, STEPHANE, DERACO, STEPHANE, VIENS, PATRICE, BORIE, NATHALIE
Year of Publication 06.01.2010
Get full text
Year of Publication 06.01.2010
Patent